<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6714">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02125903</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 06/13</org_study_id>
    <nct_id>NCT02125903</nct_id>
  </id_info>
  <brief_title>Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy</brief_title>
  <official_title>Randomized Controlled Study: Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy Relating to Early Mobilization and Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philipps University Marburg Medical Center</source>
  <oversight_info>
    <authority>Germany: Ethics Commission of the Philipps-University Department of Medicine</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The blockade of the femoral nerve (FNB) is the most common postoperative pain therapy after
      total knee replacement. Because of motor-driven weakness of the quadriceps muscle induced by
      femoral nerve block mobilization of Patients is difficult even dangerous (falls) and
      hospital stays are extended.

      An alternative method could be an adductor canal block (ACB). Anatomical studies of the
      adductor canal demonstrated that the adductor canal contains the saphenous nerve, a pure
      sensory nerve for medial and anterior aspects of the knee and the tibia without any motor
      function.

      This prospective, double-blinded, randomized study investigates the effect of FNB and ACB on
      quadriceps motor weakness and analgesia determined by Numeric Rating Scale (NRS).

      We expect the ACB to be superior in muscle strength but equal in painscore.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Timed-Up and Go-test for mobility evaluation</measure>
    <time_frame>third postoperative day</time_frame>
    <safety_issue>No</safety_issue>
    <description>The patient is observed and timed while he rises from an arm chair, walks 3 meters, turns, walks back, and sits down again.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>6, 24, 48, 72 hours postoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Numeric Rating Scale (NRS), 0-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps strength</measure>
    <time_frame>6, 24, 28, 72 hours postoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Numeric Scale (0-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ropivacaine consumption</measure>
    <time_frame>24, 48, 72 hours postoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of the total amount</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Total Knee Replacement</condition>
  <condition>Femoral Nerve Block</condition>
  <condition>Adductor Canal Block</condition>
  <arm_group>
    <arm_group_label>Continuous Adductor Canal Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous Adductor Canal block performed with:
loading dose 0,375% Ropivacaine 20ml (75mg) infusion 0,2% Ropivacaine 5ml/h
Procedure: Femoral Nerve Block. Adductor Canal Block Drug: Ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous Femoral Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous Femoral Nerve Block performed with:
loading dose 0,375% Ropivacaine 20ml (75mg) infusion 0,2% Ropivacaine 5ml/h
Procedure: Femoral Nerve Block. Adductor Canal Block Drug: Ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Regional Anesthesia  performed with 0.375% Ropivacaine 20ml (75mg)</description>
    <arm_group_label>Continuous Adductor Canal Block</arm_group_label>
    <arm_group_label>Continuous Femoral Nerve Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with knee replacement therapy and general anaesthesia

          -  informed consent

          -  &quot;timed up and go&quot; test performable

        Exclusion Criteria:

          -  emergency patients

          -  BMI &gt; 40 kg/m2

          -  American Society of Anaesthesiologists physical status (ASA) 4-5

          -  severe chronic obstructive pulmonary disease (COPD)

          -  rheumatic arthritis, diabetic Polyneuropathy, M. Parkinson

          -  nerve injury of lumbosacral plexus

          -  coagulopathy with bleeding tendency

          -  not capable of speaking or understanding german or english
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karolin Piechowiak, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Clinic for Anaesthesia And IntensivecareMedicine University of Marburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thorsten Steinfeldt, PD Dr</last_name>
    <role>Study Director</role>
    <affiliation>Clinic for Anaesthesia And IntensivecareMedicine University of Marburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karolin Piechowiak, Dr</last_name>
    <email>karolin.piechowiak@med.uni-marburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thorsten Steinfeldt, PD Dr</last_name>
    <email>thorsten.Steinfeldt@med.uni-marburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Marburg Department of Anaesthesia And Intensive Care Medicine</name>
      <address>
        <city>Marburg</city>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolin Piechowiak, Dr</last_name>
      <email>karolin.piechowiak@med.uni-marburg.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>February 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Philipps University Marburg Medical Center</investigator_affiliation>
    <investigator_full_name>Karolin Piechowiak</investigator_full_name>
    <investigator_title>Dr. Karolin Piechowiak</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
